文献速递生殖医学

严格筛查下IVF实验室未检出SARS-CoV-2

Absence of SARS-CoV-2 (COVID-19 virus) within the IVF laboratory using strict patient screening and safety criteria.
PubMed 文献 · Reprod Biomed Online · 2021-03-07

本研究前瞻性分析接受经阴道取卵患者的卵泡液、培养液和玻璃化溶液是否含SARS-CoV-2 RNA。女性术前3-5天需SARS-CoV-2 RNA阴性,男性未检测,全部采用ICSI。共分析300例卵泡液、61例培养液和200例玻璃化溶液,均未检出病毒RNA。

要点

  • 严格女性筛查和男性症状筛查下,IVF实验室样本未检出SARS-CoV-2 RNA。
  • 卵泡液、培养液和玻璃化溶液均阴性,支持实验室安全操作。
  • 可考虑快速实验室筛查 assay 用于安全操作和冷冻储存建议。

核心结论

  • 在严格安全协议下,包括女性检测和男性症状筛查,卵泡液、培养液和玻璃化溶液中未检测到SARS-CoV-2 RNA。

研究设计与样本

  • 前瞻性临床研究,所有经阴道取卵女性术前3-5天SARS-CoV-2 RNA检测阴性,男性伴侣未检测,全部采用ICSI。

主要发现

  • 共分析300例患者的卵泡液、61例患者的培养液和200例患者的玻璃化溶液,所有样本SARS-CoV-2 RNA均为阴性。

临床怎么用

  • 严格筛查协议下IVF实验室操作未检出SARS-CoV-2 RNA,支持安全实验室操作包括冷冻储存建议。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Is there a risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral exposure and potential cross-contamination from follicular fluid, culture media and vitrification solution within the IVF laboratory using strict patient screening and safety measures? DESIGN: This was a prospective clinical study. All women undergoing transvaginal oocyte retrieval were required to have a negative SARS-CoV-2 RNA test 3-5 days prior to the procedure. Male partners were not tested. All cases used intracytoplasmic sperm injection (ICSI). The first tube of follicular fluid aspirated during oocyte retrieval, drops of media following removal of the embryos on day 5, and vitrification solution after blastocyst cryopreservation were analysed for SARS-CoV-2 RNA. RESULTS: In total, medium from 61 patients, vitrification solution from 200 patients and follicular fluid from 300 patients was analysed. All samples were negative for SARS-CoV-2 viral RNA. CONCLUSIONS: With stringent safety protocols in place, including testing of women and symptom-based screening of men, the presence of SARS-CoV-2 RNA was not detected in follicular fluid, medium or vitrification solution. This work demonstrates the possibility of implementing a rapid laboratory screening assay for SARS-CoV-2 and has implications for safe laboratory operations, including cryostorage recommendations.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Rajput SK, Khan SA, Goheen BB, et al. Absence of SARS-CoV-2 (COVID-19 virus) within the IVF laboratory using strict patient screening and safety criteria. Reprod Biomed Online. 2021. PMID: 33814309. doi:10.1016/j.rbmo.2021.03.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。